1. Home
  2. WNEB vs BWAY Comparison

WNEB vs BWAY Comparison

Compare WNEB & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western New England Bancorp Inc.

WNEB

Western New England Bancorp Inc.

HOLD

Current Price

$12.91

Market Cap

259.2M

Sector

Finance

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$19.58

Market Cap

337.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WNEB
BWAY
Founded
1853
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Savings Institutions
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
259.2M
337.9M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
WNEB
BWAY
Price
$12.91
$19.58
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$11.00
$23.50
AVG Volume (30 Days)
53.7K
74.4K
Earning Date
01-27-2026
11-11-2025
Dividend Yield
2.17%
N/A
EPS Growth
27.15
213.09
EPS
0.66
0.13
Revenue
$79,080,000.00
$49,094,000.00
Revenue This Year
N/A
$330.76
Revenue Next Year
$7.48
$22.24
P/E Ratio
$19.60
$61.21
Revenue Growth
9.08
27.08
52 Week Low
$7.63
$7.84
52 Week High
$13.95
$19.80

Technical Indicators

Market Signals
Indicator
WNEB
BWAY
Relative Strength Index (RSI) 56.18 65.76
Support Level $13.20 $15.97
Resistance Level $13.49 $17.38
Average True Range (ATR) 0.33 0.74
MACD -0.05 0.21
Stochastic Oscillator 19.55 86.68

Price Performance

Historical Comparison
WNEB
BWAY

About WNEB Western New England Bancorp Inc.

Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: